The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients
Objective: To establish the gut microbiome composition of de novo Parkinson’s disease (PD) patients with no history of dopaminergic medication use. Background: PD is often…Differential temporal processing across Lewy body disorders and relation to cognitive fluctuations
Objective: To characterize differences in interval timing between patients with Parkinson’s disease and Dementia with Lewy bodies (DLB) and evaluate their relationship to cognitive fluctuations…Anxiety and dopaminergic stimulation in patients with Parkinson´s disease.
Objective: To report two patients with Parkinson disease and describe the response of this non motor symptom to dopaminergic therapy. Background: Anxiety is frequent comorbidity…Dopaminergics are alternative for the treatment of Bell`s paralysis in acute period
Objective: To study the possibility of using dopaminergic medicines for the treatment of Bell`s paralysis in acute period. Background: In previous reports we conjectured that…Could the rate of dopaminergic medications reduction affect outcome after STN-DBS?
Objective: A retrospective analysis of the rate of dopaminergic drugs reduction following subthalamic nucleus Deep Brain Stimulation (STN-DBS) in a group of Parkinson’s disease patients…Patient Perceptions of Dopaminergic Therapy Withdrawal in Parkinson’s disease
Objective: To survey Parkinson’s disease (PD) patients regarding their willingness and experience in withdrawal of their dopaminergic medications. Background: Parkinson’s disease patients are asked to…Vowel characteristics associated with Parkinson’s disease in Cantonese
Objective: Dopaminergic treatment has been reported to help motor problem associated with Parkinson's disease (PD), but not speech motor. The current study examined vowel articulation…Effect of Urinary Dysfunction on Fatigue Syndrome in Parkinson’s disease
Objective: to investigate the relationship between urinary dysfunction and fatigue syndrome in Parkinson`s disease Background: Fatigue syndrome (FS) is an overwhelming sense of tiredness, lack…Is there a significant relationship between weight loss and prevalence of side effects of Parkinsonian medication? A retrospective, single-centre analysis, South Wales, UK.
Objective: To investigate if there is a significant relationship between weight loss in persons with Parkinson’s disease and side-effect incidence, and if so to what…Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage
Objective: We examined the effect of dopaminergic medication on executive function in 24 drug-naïve PD patients (de novo group) and in 21 PD patients on…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.